HIGHLIGHTS
- who: Viktu00f3ria Jenei from the Department of Immunology, Faculty of Medicine, University of Debrecen, Egyetem Square, Debrecen, Hungary have published the research: Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells, in the Journal: (JOURNAL)
- what: The authors investigated two platinum-based antineoplastic agents; oxaliplatin and cisplatin, with the ability to crosslink with the urine bases on the DNA leading to DNA damage and subsequently apoptosis within cancer cells and two anthracyclines; doxorubicin and epirubicin with DNA intercalation ability and consequently inhibition of nucleic_acid and protein . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.